share_log

HC Wainwright & Co. Reiterates Buy on Corcept Therapeutics, Maintains $38 Price Target

Moomoo 24/7 ·  Apr 23 13:28

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $38 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment